Taipei Medical University Institutional Repository:Item 987654321/63322
English  |  正體中文  |  简体中文  |  全文笔数/总笔数 : 45069/58245 (77%)
造访人次 : 2341640      在线人数 : 240
RC Version 7.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
搜寻范围 查询小技巧:
  • 您可在西文检索词汇前后加上"双引号",以获取较精准的检索结果
  • 若欲以作者姓名搜寻,建议至进阶搜寻限定作者字段,可获得较完整数据
  • 进阶搜寻


    jsp.display-item.identifier=請使用永久網址來引用或連結此文件: http://libir.tmu.edu.tw/handle/987654321/63322


    题名: Casein kinase 2α媒介Interleukin-6誘導人類肺纖維母細胞結締組織生長因子表現之角色探討
    Studies on the role of casein kinase 2α mediated interleukin-6-induced connective tissue growth factor expression in human lung fibroblasts
    作者: 莊沛儒
    JHUANG, PEI-RU
    贡献者: 醫學科學研究所碩士班
    林建煌
    陳炳常
    关键词: 嚴重氣喘;肺纖維化;IL-6;CK2;YY1;CTGF
    severe asthma;pulmonary fibrosis;IL-6;CK2;YY1;CTGF
    日期: 2023-07-13
    上传时间: 2023-12-15 14:05:17 (UTC+8)
    摘要: 約有10 %的氣喘患者對類固醇治療無反應,並伴隨嚴重的呼吸道重塑及呼吸道阻塞,被定義為嚴重氣喘(severe asthma, SA)。先前有研究指出Interleukin-6 (IL-6)參與在發炎反應及肺部纖維化。Casein kinase 2 (CK2)透過調控β-catenin signaling參與在bleomycin (BLM)誘導的小鼠肺纖維化中。Ying Yang 1 (YY1)在特發性肺纖維化(idiopathic pulmonary fibrosis, IPF)患者中過度表現。但在IL-6誘導CTGF表現的途徑中,CK2及YY1的分子機制仍不清楚。因此我們將探討在人類肺纖維母細胞中,CK2及YY1調控IL-6誘導CTGF表現之角色。在本研究中,我們發現在人類肺纖維母細胞中,CK2抑制劑apigenin抑制IL-6誘導的CTGF表現有濃度關係,且轉染CK2α、CK2α’以及CK2β的siRNA都會抑制IL-6誘導的CTGF表現。進一步研究發現IL-6誘導CK2β以及CK2α/α’磷酸化,且轉染CK2β siRNA可以抑制CK2α及CK2α’磷酸化。利用免疫螢光染色法發現,在IL-6刺激後CK2α會由細胞質進入細胞核中,而CK2α’以及CK2β則不會。此外,轉染YY1 siRNA後能夠抑制IL-6誘導的CTGF表現,進一步發現IL-6可誘導YY1磷酸化。接續利用共同免疫沉澱法發現,在IL-6刺激後CK2α會與YY1結合形成complex,而CK2α’與CK2β則不會與YY1結合。我們進一步利用染色質免疫沉澱法發現以IL-6刺激後CK2α及YY1會結合在CTGF promoter上的YY1 binding site,CK2α’與CK2β則不會。綜上所述,在人類肺纖維母細胞中,IL-6透過活化CK2α及YY1,並使CK2α及YY1形成complex,結合至CTGF promoter上,進而促進CTGF表現。說明CK2α及YY1可能是未來發展肺纖維化治療的標的。
    About 10 % of asthma patients have steroids-insensitive along with airway remodeling and airway obstruction, which is defined as severe asthma. Previous studies suggested that interleukin-6 (IL-6) was involved in inflammation and pulmonary fibrosis. Casein kinase 2 (CK2) was involved in bleomycin (BLM)-induced pulmonary fibrosis in mice by regulation of β-catenin signaling. Ying Yang 1 (YY1) was overexpressed in patients with idiopathic pulmonary fibrosis (IPF). However, the molecular mechanism of CK2 and YY1 in IL-6-induced CTGF expression remain unclear. Therefore, we will explore the role of CK2 and YY1 involved in IL-6-induced CTGF expression in human lung fibroblasts. In this study, we found that CK2 inhibitor, apigenin, inhibited IL-6-induced CTGF expression in human lung fibroblasts in a dose-dependent manner. Transfection with CK2α, CK2α’ and CK2β siRNA attenuated IL-6-induced CTGF expression. Furthermore, IL-6 increased CK2β and CK2α/α’ phosphorylation. Transfection of CK2β siRNA inhibited the phosphorylation of CK2α and CK2α’. Using immunofluorescence, we found that IL-6 induced the translocation of CK2α from cytosol to nucleus, but not CK2α’ and CK2β. Moreover, IL-6-induced CTGF expression was decreased by the transfection of YY1 siRNA. IL-6 increased YY1 phosphorylation in time-dependent manner. Subsequently, using the co-immunoprecipitation, we found that IL-6 stimulated CK2α and YY1 formed a transcriptional complex, while CK2α’ and CK2β would not bind to YY1. Moreover, using ChIP assay, we found that IL-6 stimulated CK2α and YY1 binding to YY1 binding site at CTGF promoter, but not CK2α’ and CK2β. In conclusion, IL-6 activates CK2α and YY1, then stimulates formation of CK2α and YY1 complex and recruitment to the CTGF promoter region, and eventually promotes the production of CTGF in human lung fibroblasts. CK2α and YY1 might be a therapeutic target of pulmonary fibrosis.
    描述: 碩士
    指導教授:林建煌
    共同指導教授:陳炳常
    委員:林建煌
    委員:陳炳常
    委員:黃聰龍
    委員:許銘仁
    委員:蕭哲志
    数据类型: thesis
    显示于类别:[醫學科學研究所] 博碩士論文

    文件中的档案:

    档案 描述 大小格式浏览次数
    index.html0KbHTML45检视/开启


    在TMUIR中所有的数据项都受到原著作权保护.

    TAIR相关文章

    著作權聲明 Copyright Notice
    • 本平台之數位內容為臺北醫學大學所收錄之機構典藏,包含體系內各式學術著作及學術產出。秉持開放取用的精神,提供使用者進行資料檢索、下載與取用,惟仍請適度、合理地於合法範圍內使用本平台之內容,以尊重著作權人之權益。商業上之利用,請先取得著作權人之授權。

      The digital content on this platform is part of the Taipei Medical University Institutional Repository, featuring various academic works and outputs from the institution. It offers free access to academic research and public education for non-commercial use. Please use the content appropriately and within legal boundaries to respect copyright owners' rights. For commercial use, please obtain prior authorization from the copyright owner.

    • 瀏覽或使用本平台,視同使用者已完全接受並瞭解聲明中所有規範、中華民國相關法規、一切國際網路規定及使用慣例,並不得為任何不法目的使用TMUIR。

      By utilising the platform, users are deemed to have fully accepted and understood all the regulations set out in the statement, relevant laws of the Republic of China, all international internet regulations, and usage conventions. Furthermore, users must not use TMUIR for any illegal purposes.

    • 本平台盡力防止侵害著作權人之權益。若發現本平台之數位內容有侵害著作權人權益情事者,煩請權利人通知本平台維護人員([email protected]),將立即採取移除該數位著作等補救措施。

      TMUIR is made to protect the interests of copyright owners. If you believe that any material on the website infringes copyright, please contact our staff([email protected]). We will remove the work from the repository.

    Back to Top
    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - 回馈